About 54.5% (n = 36) of GBM tissues express, although at lower level respect to NHA, NHB, or EHB samples (Figure 8a), TRPML-1 mRNA, whereas 45.5% (n = 30) of the samples were TRPML-1 negative. This evidence concerns the gene MCOLN1 and glioblastoma.